...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Inflammatory stress induces statin resistance by disrupting 3-Hydroxy-3-Methylglutaryl-CoA reductase feedback regulation
【24h】

Inflammatory stress induces statin resistance by disrupting 3-Hydroxy-3-Methylglutaryl-CoA reductase feedback regulation

机译:炎性应激通过破坏3-羟基-3-甲基戊二酰辅酶A还原酶反馈调节来诱导他汀类药物耐药。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE - : The risk of cardiovascular disease is increased by up to 33 to 50× in chronic inflammatory states and convention doses of statins may not provide the same cardiovascular protection as in noninflamed patients. This study investigated whether the increase in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCoA-R)-mediated cholesterol synthesis observed under inflammatory stress was resistant to the action of statins and if so, whether this was because of interference with the sterol regulatory element binding protein cleavage-activating protein pathway. APPROACH AND RESULTS - : Inflammatory stress was induced by adding cytokines (interleukin-1β, tumor necrosis factor-α, and interleukin-6) and lipopolysaccharides to vascular smooth muscle cells in vitro and by subcutaneous casein injection in apolipoprotein E/scavenger receptors class A/CD36 triple knockout mice in vivo. Inflammatory stress exacerbated cholesterol ester accumulation and was accompanied in vitro and in vivo by increased HMGCoA-R mRNA and protein expression mediated via activation of the sterol regulatory element binding protein cleavage-activating protein/sterol regulatory element binding protein-2 pathway. Atorvastatin reduced HMGCoA-R enzymatic activity and intracellular cholesterol synthesis in vitro. However, inflammatory stress weakened these suppressive effects. Atorvastatin at concentrations of 16 μmol/L inhibited HMGCoA-R activity by 50% in vascular smooth muscle cells, but the same concentration resulted in only 30% of HMGCoA-R activity in vascular smooth muscle cells in the presence of interleukin-1β. Knocking down sterol regulatory element binding protein cleavage-activating protein prevented statin resistance induced by interleukin-1β, and overexpression of sterol regulatory element binding protein cleavage-activating protein induced statin resistance even without inflammatory stress. In vivo, the amount of atorvastatin required to lower serum cholesterol and decrease aortic lipid accumulation rose from 2 to 10 mg/kg per day in the presence of inflammatory stress. CONCLUSIONS - : Increased cholesterol synthesis mediated by HMGCoA-R under inflammatory stress may be one of the mechanisms for intracellular lipid accumulation and statin resistance.
机译:目的-:在慢性炎症状态下,心血管疾病的风险最多可增加33至50倍,常规剂量的他汀类药物可能无法提供与非发炎患者相同的心血管保护作用。这项研究调查了在炎性应激下观察到的3-羟基-3-甲基戊二酰辅酶A-CoA还原酶(HMGCoA-R)介导的胆固醇合成的增加是否对他汀类药物具有抗药性,如果是,这是否是由于对甾醇的干扰调节元件结合蛋白裂解激活蛋白途径。方法和结果-:通过向血管平滑肌细胞中添加细胞因子(白介素-1β,肿瘤坏死因子-α和白介素-6)和脂多糖,以及皮下注射酪蛋白A类载脂蛋白E /清道夫受体,诱导了炎症应激/ CD36体内三联敲除小鼠。炎性应激加剧了胆固醇酯的积累,并在体内和体外伴随着HMGCoA-R mRNA和蛋白表达的增加,而HMGCoA-R mRNA和蛋白表达则是通过激活固醇调节元件结合蛋白裂解激活蛋白/固醇调节元件结合蛋白2途径而介导的。阿托伐他汀在体外降低了HMGCoA-R的酶活性和细胞内胆固醇的合成。但是,炎性应激减弱了这些抑制作用。阿托伐他汀的浓度为16μmol/ L,在血管平滑肌细胞中抑制HMGCoA-R活性50%,但在存在白介素-1β的情况下,相同浓度仅导致血管平滑肌细胞中HMGCoA-R活性的30%。敲低固醇调节元件结合蛋白裂解激活蛋白可防止白介素-1β诱导的他汀类药物耐药,即使没有炎性应激,固醇调节元件结合蛋白裂解激活蛋白也可诱导他汀类药物抵抗。在体内,在存在炎症应激的情况下,降低血清胆固醇和减少主动脉脂质蓄积所需的阿托伐他汀的量从每天2毫克/千克增加到10毫克/千克。结论-:HMGCoA-R在炎性应激下介导的胆固醇合成增加可能是细胞内脂质蓄积和他汀类药物耐药的机制之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号